A mild favorable effect of soy protein with isoflavones on body composition--a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women.

School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR.
International journal of obesity (2005) (Impact Factor: 5.39). 11/2009; 34(2):309-18. DOI: 10.1038/ijo.2009.236
Source: PubMed

ABSTRACT In vitro and animal studies suggested that soy protein and isoflavones promote weight and body fat loss. However, clinical trials in humans were few and the effects remained uncertain.
To examine whether soy protein with isoflavones and isoflavone extracts exert beneficial effects on body composition among postmenopausal women.
A double-blind randomized placebo-controlled trial was conducted among 180 postmenopausal Chinese women with mild hyperglycemia. After a 2-week adaptation, participants were randomly assigned to one of the three arms to receive 15 g soy protein and 100 mg isoflavones (Soy group), or 15 g milk protein and 100 mg isoflavones (Iso group), or 15 g milk protein (placebo group) on a daily basis for 6 months.Results:We observed a mild but significant favorable effect of soy protein with isoflavones on the changes of body weight (BW), body mass index, and body fat percentage relative to isoflavone extracts and milk protein after 6-month supplementation. The mean differences of BW between the Soy and the Iso groups were -0.75 kg (95% CI: -1.363 to -0.136, P=0.017), and between the Soy and the placebo groups were -0.60 kg (95% CI: -1.209 to -0.019, P=0.047). The mean difference of change percentage in body fat percentage between the Soy and the Iso groups was -3.74% (95% CI: -6.88 to -0.60%, P=0.02), and between the Soy and the placebo groups was -2.54% (95% CI: -5.69 to 0.12%. P=0.08).
Six-month supplementation of soy protein with isoflavones had a mild favorable effect on body composition in postmenopausal women.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this pilot study was to begin to examine the effect of dietary protein source (soy protein versus non-soy protein) during weight loss on body composition, and cardiometabolic and functional decline risk factors in older, abdominally obese adults. Two-arm, single-blind, randomized, controlled trial. Wake Forest School of Medicine, Winston-Salem NC 27157, USA. 25 older (68.4±5.5 years, 88% female), abdominally obese (BMI: 35.1±4.3 kg/m2; WC: 101.4±13.1 cm) men and women were randomized to participate in the study. A 12-week weight loss intervention, with participants randomized to consume soy protein-based meal replacements (S; n=12) or non-soy protein-based meal replacements (NS; n=12), in addition to prepared meals, and all participants targeted to receive an individualized caloric deficit of 500 kcal/day. Body weight and composition (assessed via DXA and CT), conventional biomarkers of cardiometabolic risk, and physical performance measures were assessed pre- and post-intervention. Additional endpoints of feasibility (accrual, participation, retention, compliance, and safety) are reported. A total of 24 participants (87% female) completed the study (96% retention) and lost an average of 7.8±3.0 kg over the 12-week period, with no difference seen between groups (p=0.83). Although nearly all measures of global and regional body composition were significantly reduced following the 12-week intervention, differences were not observed between groups. Among cardiometabolic risk factors and physical performance measures, only diastolic blood pressure was significantly lower in the NS group compared to the S group (66.7±2.7 mmHg vs 73.5±2.7 mmHg, respectively; p=0.04). Interestingly, in groups combined, despite significant reductions in body weight and lean mass, no significant changes in 400-meter walk time (+5.3±43.4 s), short physical performance battery score (+0.1±1.0), grip strength (-0.3±3.2 kg), or relative knee extensor strength (-0.0±0.0 N/m/cm3 thigh muscle volume) were observed. Data presented here suggest that a 12-week weight loss intervention, which incorporates S and NS meal replacement products, is associated with clinically significant weight loss and improvements in several parameters of cardiometabolic risk and unchanged physical function and strength. RESULTS do not differ by protein source and suggest that soy protein is at least as good as other protein sources for weight loss during low-calorie dietary interventions in older adults.
    The Journal of Nutrition Health and Aging 01/2015; 19(1):87-95. DOI:10.1007/s12603-015-0438-7 · 2.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Overweight and obesity affect more than 66% of the adult population and are associated with a variety of chronic diseases. Weight loss has then beneficial effects in reducing health risks associated with chronic diseases. In recent decades, weight management has evolved into a multidisciplinary approach, combining low-calorie diets with physical activity and nutritional supplementation. This could help weight loss by inducing a reduction in caloric intake, an increased lipolysis or a reduction of the nervous system feedback of hunger sensation. The study presented in this work aimed at evaluating the efficacy of a dietary supplemental containing phloridzin, isoflavones and probiotics (Re-Code®), as an adjuvant in reducing body weight and fat mass in slightly overweight women. Phyto-supplement consumption was included in a body weight reduction programme including a mild hypocaloric diet and moderate daily physical activity. A randomised, double-blinded, placebo-controlled trial was conducted on 40 slightly overweight women aged 30 to 54. Women taking the phyto-supplement showed greater reductions in body weight, fat mass and waist, thigh and buttock circumference than the control group. Moreover, the used phyto-supplement proved to be an effective adjuvant in body weight and fat mass reduction when associated with both a mild low-calorie diet and moderate physical activity in overweight women.
    Current Topics in Nutraceutical Research 01/2013; 11(1-2):21-28. · 0.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human clinical trials targeted at preventing gains in body weight using soy protein and isoflavones are limited to adults and yield conflicting results. We hypothesized that daily intake of soy protein/isoflavones would attenuate gains in body weight to a greater extent than a casein-based control in 18 to 19 year-old females. To test this hypothesis, we conducted a randomized, double blind, placebo-controlled trial over 16 weeks to examine the effects of a soy protein/isoflavone-based meal replacement (experimental group) versus a casein-based meal replacement (control group) on body weight and body composition variables in female college freshmen (N = 120). Fat mass (FM), fat-free soft tissue mass (FFST), and percent body fat (%BF) were measured using dual energy X-ray absorptiometry (DXA; Delphi A). Repeated measures mixed models were used to determine the effects of treatment on anthropometric and body composition variables (body weight, waist circumference, FM, FFST, and %BF). No significant group×time interactions were observed, even when body mass index was controlled for in the analysis. Over 16 weeks, body weight, FM, FFST, and %BF significantly increased in both groups (P < .05). Our findings show that female college freshmen gained a significant amount of weight over the course of the 16-week study. Gains in body weight and FM were similar among participants assigned to the soy protein/isoflavone- and the casein-based meal replacements. Future research is warranted to determine the effects of soy protein/isoflavone- and casein-based meal replacements versus a non-intervention (i.e., non-protein based) control.
    Nutrition research 01/2014; 34(1):66-73. DOI:10.1016/j.nutres.2013.09.005 · 2.59 Impact Factor


Available from
Apr 24, 2015